Company Overview: Myomo

Industry News

30 Nov

Myomo, Inc. Announces Pricing of Public Offering

CAMBRIDGE, Mass.–(BUSINESS WIRE)– Myomo, Inc. (NYSE American: MYO), a commercial stage medical robotics company, today announced that it has priced an underwritten public offering of 4,175,000 shares of its common stock and accompanying warrants to purchase 4,175,000 shares of common stock. Each share of common stock is being sold...

Read more

29 Nov

Myomo Expands MyoPro® Centers of Excellence Program

CAMBRIDGE, Mass.–(BUSINESS WIRE)– Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced the addition of six new orthotics and prosthetics (O&P) locations to its Center of Excellence (CoE) program, which recognizes top O&P practices that support the MyoPro line of powered...

Read more

28 Nov

Myomo, Inc. to Present at the 10th Annual LD Micro Main Event

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced that it will be presenting at the 10th annual LD Micro Main Event on Tuesday, December 5th at 9:30 AM PST / 12:30 PM EST at the Luxe Sunset Boulevard Hotel in Los...

Read more

7 Nov

Myomo, Inc. Reports Third Quarter 2017 Results

CAMBRIDGE, Mass.–(BUSINESS WIRE)– Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today reports its financial results for the three and nine months ended September 30, 2017. Highlights and Achievements in the Third Quarter 2017 and Year To-date: The third quarter of 2017...

Read more

7 Nov

Myomo, Inc. Issues November 2017 Shareholder Letter

CAMBRIDGE, Mass.–(BUSINESS WIRE)– Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today issued a letter to shareholders to give an update on third quarter 2017 and ongoing MyoPro® commercial activities. An accompanying digital shareholder letter can be viewed at: shareholderletters.myomo.com/q3-17. Dear Fellow Shareholders:...

Read more

3 Nov

Myomo Enters Canadian Market

CAMBRIDGE, Mass.–(BUSINESS WIRE)– Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced that its Application for a Canadian Medical Device License has been approved by Health Canada. With the license, Myomo and its distribution partner, Ottobock, are now entering the Canadian...

Read more

30 Oct

Myomo, Inc. to Report Third Quarter 2017 Results on November 6, 2017

CAMBRIDGE, Mass.–(BUSINESS WIRE)– Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced that it will release its unaudited financial results for the quarter ended September 30, 2017 on Monday, November 6, 2017, after the US markets close. The Company will host...

Read more

17 Oct

Myomo, Inc. Launches Awareness Program for Veterans of the U.S. Armed Forces

CAMBRIDGE, Mass.–(BUSINESS WIRE)– Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical device company, today announced the launch of MyoPro For Veterans, a strategic awareness program that broadens accessibility of MyoPro powered upper limb orthotics (arm brace) to the many veterans of the U.S. Armed Forces...

Read more

Page 1 of 212

Enter your email address to receive notifications of new posts by email.

Latest Tweets

Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address